[Prazosin in the combined treatment of moderate to severe hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D004232:Diuretics / Q000627:therapeutic use; D004244:Dizziness / Q000139:chemically induced; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000009:adverse effects / Q000627:therapeutic use*; D011674:Pulse / Q000187:drug effects; D011799:Quinazolines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D011799:Quinazolines; D011224:Prazosin
Prazosin in der Kombinationsbehandlung der mittelschweren bis schweren Hypertonie.